← Evidence map

ReviewThe Lancet. Oncology2014

Regulatory and clinical considerations for biosimilar oncology drugs.

Charles L Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25456378